The role of meropenem in bacterial meningitis;Papel de meropenem en la meningitis bacteriana

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 15, Issue SUPPL. 1, 1997, Pages 57-61

  Viladrich, Pedro Fernández ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MENINGITIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; GRAM NEGATIVE INFECTION; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANIMALS; BLOOD-BRAIN BARRIER; CHILD; CROSS INFECTION; DISEASE MODELS, ANIMAL; HUMANS; MENINGITIS, BACTERIAL; RABBITS; THIENAMYCINS;

EID: 0030929194     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wiseman LR, Wagstaff AJ, Brogden RN, Bryson HM. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1995; 50: 73-101.
2. Jones RM, Barry AI, Thornsberry C. In vitro studies of meropenem. J Antimicrob Chemother 1989; 24 (Supl A): 9-29.
3. Edwards JR, Turner PJ. Laboratory data which differentiate meropenem and imipenem. Scand J Infect Dis 1995; 96 (Supl): 5-10.
4. Catchpole CR, Webs R, Thorber D, Andrews JM. In vitro activity of L-627, a new carbapenem. Antimicrob Agents Chemother 1992; 36: 1.928-1.934.
5. Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilites of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob Agents Chemother 1994; 38: 898-900.
6. Fuchs PC, Barry AL, Brown SD. Pneumococcal susceptibility to meropenem. J Antimicrob Chemother 1996; 37: 1.036-1.037.
7. Jorgensen JH, Maher LA, Howell AW. Activity of meropenem against antibiotic-resistant or infrecuently encountered gramnegative bacilli. Antimicrob Agents Chemother 1991; 35: 2.410-2.414.
8. Wong WK, Wright HT, Ross LA, Mason WH, Inderlied CB, Kim KS. Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J 1991; 10: 122-125.
9. Norrby SR, Newell PA, Faulkner KL, Lesky W. Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem. J Antimicrob Chemother 1995; 36 (Supl A): 207-223.
10. Dagan R, Velghe L, Rodda JL, Klugman KP. Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J Antimicrob Chemother 1994; 34: 175-179.
11. Hutchison M, Faulkner KL, Turner PJ, Haworth SJ, Sheikl W, Nadler H et al. A compilation of meropenem tissue distribution data. J Antimicrob Chemother 1995; 35 (Supl A): 43-56.
12. Nairn K, Shepherd GL, Edwards JR. Efficacy of meropenem in experimental meningitis. J Antimicrob Chemother 1995; 36 (Supl A): 73-84.
13. Friedland IR, Paris M, Ehrett S, Hickey S, Olsen K, McCracken GH Jr. Evaluation of antimicrobial regimens for treatment of experimental penicillin -and cephalosporin- resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993; 37: 1.630-1.636.
14. Klugman KP, Dagan R. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem meningitis study group. Antimicrob Agents Chemother 1995; 39: 1.140-1.146.
15. Donnelly JP, Horrevorts AM, Sauerwein RW, De Pauw BE. High-dose meropenem in meningitis due to Pseudomonas aeruginosa [carta]. Lancet 1992; 339: 1.117.
16. Chmelik V, Gutvirth J. Meropenem treatment of post-traumatic meningitis due to Pseudomonas aeruginosa [carta]. J Antimicrob Chemother 1993; 32: 922-923.
17. Schmutzhard E, Williams KJ, Vutmirovits G, Chmelik V, Pfausler B, Featherstone A. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. J Antimicrob Chemother 1995; 36 (Supl A): 85-97.
18. Klugman KP, Friedland IR, Bradlwy JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39: 1.988-1.992.